// App-Quantinova.ai

: Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial

Researchers

Presenter

  • Manuela Funke-Chambour

Principal Investigators

  • Christian Clarenbach

  • Katrin Hostettler

  • Martin Brutsche

  • Thomas K. Geiser

  • Sabina A. Guler

Medical Centers

  • Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland, Bern, Switzerland

  • Division of Nuclear Medicine, University of Zurich, Zurich, Switzerland

  • Clinics of Respiratory Medicine, University Hospital of Basel, University Basel, Basel, Switzerland

  • Department of Pulmonary Medicine, Kantonspital St. Gallen, St. Gallen, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Azithromycin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Cross Over

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved